{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/76420-534#drug","name":"BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"76420-534"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA209069"},{"@type":"PropertyValue","propertyID":"UNII","value":"56W8MW3EN1|5Q187997EE"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"597cbc69-84b1-4255-bed9-53d0c6dc2134"}],"activeIngredient":"BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE DIHYDRATE","administrationRoute":["SUBLINGUAL"],"dosageForm":"TABLET","manufacturer":{"@type":"Organization","name":"Asclemed USA, Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA209069","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=597cbc69-84b1-4255-bed9-53d0c6dc2134","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=76420-534"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-03T10:02:51.123Z"}}